Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

News

$Seelos Therapeutics(SEEL.US)$ Seelos Therapeutics Selects SLS-002 (Intranasal Racemic Ketamine) For Inclusion In The U.S. Department Of Defense's Adaptive Platform Trial To Evaluate Potential Treatments For Post-traumatic Stress Disorder
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
2
+0
Translate
Report
4506 Views
Comment
Sign in to post a comment
    1795Followers
    29Following
    21KVisitors
    Follow